Quality of Life in Hypoparathyroidism: Burden Across Four Domains

Dr. Ferenczi structures her response around four validated domains aligned with the Hypoparathyroidism Patient Experience Scale (HPES): physical functioning, cognitive functioning, psychological wellbeing, and daily life and social functioning.

In the physical domain, fatigue and reduced energy are the most consistent complaints. Patients report impaired ability to exercise, reduced mobility, muscle cramps, spasms, stiffness, weakness, and temperature sensitivity. The energy and fatigue subscale of the SF-36 is where hypoparathyroid patients diverge most sharply from healthy controls.

Cognitively, brain fog is described as the most disabling and underappreciated feature of the disease. The vast majority of symptomatic patients report memory difficulties, word-finding problems, inability to concentrate or multitask, and impaired comprehension—frequently leading to loss of work productivity. A recent study found reduced hippocampal volume in more symptomatic postsurgical patients, raising the possibility of structural brain changes contributing to cognitive impairment.

Psychologically, anxiety, depression, and frustration are very common. Patients with non-surgical or genetic forms carry an elevated baseline risk of neuropsychiatric disorders. In daily life and social functioning, relationship strain, reduced social participation, and needing to pace activities around symptoms are recurring consequences.

Dr. Ferenczi notes that some patients remain essentially asymptomatic despite biochemical abnormalities, and this variability is not yet understood. Importantly, standard calcium and vitamin D normalization does not fully resolve symptoms in many patients. On etiology, she references a Danish study showing non-surgical and surgical patients reported comparably impaired quality of life—both scoring worse than patients with diabetes or heart disease—suggesting etiology does not reliably predict symptom burden. Additional validated tools include the daily diary questionnaire, the WHO-5 wellbeing index, the HADS, and the EQ-5D.

In the next episode, "Neurologic, Neurocognitive, and Cardiovascular Complications of Hypoparathyroidism," Dr. Shoback details the full spectrum of neurologic complications from brain fog and seizures to Parkinson's-like movement disorders, and Dr. Lubitz reviews the evidence linking hypoparathyroidism to elevated cardiovascular risk.